ReviewMolecular biology reports2026
Immune cell dynamics in neurological disorders: from inflammation to microgliopathy and Neuron-Glia crosstalk.
Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The immune system is a complex network of cells and molecules that preserves homeostasis and provides defence against pathogens. Within the central nervous system (CNS), immune cells perform distinct yet integrated roles, balancing neuronal survival with inflammatory responses. Neuroinflammation is a hallmark of several neurological disorders, where immune activation may become maladaptive and drive neurodegeneration. Microglia, the resident macrophage-like immune cells of the brain, represent a unique interface between immune and neural function. They regulate synaptic pruning, release trophic factors, and respond to injury; however, their chronic or patchy activation leads to microgliopathy, an emerging pathological state underpinning diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), and ischemic stroke. This review traces the evolution of immune involvement from peripheral to central contexts, examines microglial signalling mechanisms in health and disease, and highlights how dysregulated neuron–microglia communication contributes to disease pathology. This review also explores biomarkers, signalling cascades such as NF-κB, MAPK, JAK/STAT, and calcium-mediated pathways, and discuss future perspectives on targeting microglial states for therapeutic intervention.
Indexed as
Identifiers
41670842What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.